Central African Republic (the) documents

Annual progress reports

Countries no longer submit annual progress reports. Please refer to the joint appraisal report and Multi-Stakeholder Dialogue documents on this page.

Annual progress report Central African Republic 2009

Annual progress report Central African Republic 2005

Annual progress report Central African Republic 2014

Annual progress report Central African Republic 2009 [Français]

Annual progress report Central African Republic 2001 [Français]

Annual progress report Central African Republic 2014 [Français]

Annual progress report Central African Republic 2008 [Français]

Annual progress report Central African Republic 2003

Annual progress report Central African Republic 2013

Annual progress report Central African Republic 2008

Annual progress report Central African Republic 2002

Annual progress report Central African Republic 2013 [Français]

Annual progress report Central African Republic 2007

Annual progress report Central African Republic 2002 [Français]

Annual progress report Central African Republic 2012

Annual progress report Central African Republic 2007 [Français]

Annual progress report Central African Republic 2011 [French]

Annual progress report Central African Republic 2006 [Français]

Annual progress report Central African Republic 2010

Annual progress report Central African Republic 2004 [Français]

The joint appraisal report and Multi-Stakeholder Dialogue

The joint appraisal is an in-country, multi-stakeholder review of the implementation progress and performance of Gavi's vaccine and cash grant support to the country, and of its contribution to improved immunisation outcomes. The outcome of the appraisal is the completed "joint appraisal report" that captures Gavi grant performance as well as implementation challenges. The joint appraisal report informs discussions with national coordination mechanisms on areas where greater national investments and efforts, as well as technical support, are needed.

In 2020/2021, as a result of the COVID-19 pandemic, Multi-stakeholder dialogue (MSD) documents temporarily replaced the traditional Joint Appraisal to ensure that Gavi’s continuing support to the EPI programme be aligned with realities at country level.

Joint Appraisal CAR 2020 [French]

Joint Appraisal CAR 2019

Joint Appraisal CAR 2018

Joint Appraisal CAR 2018 [French]

Rapport de l'évaluation conjointe RCA 2017

Rapport de l'évaluation conjointe RCA 2016

Rapport de l’évaluation conjointe RCA 2015

Rapport de l'évaluation conjointe RCA 2014

Approved proposals

All eligible countries are invited to submit proposals for Gavi support. 

Proposal for NVS-Measles follow up camp support 2021:Central African Republic

Date of Gavi approval:

Proposal for NVS-Measles follow up camp 2017:Central African Republic

Date of Gavi approval:

Proposal for CCEOP support(2018-2019): CAR

Date of Gavi approval:

Proposal for HSS Support (2017-2019): CAR

Date of Gavi approval:

Proposal for NVS - MenA routine support: Central African Republic

Date of Gavi approval:

Proposal for NVS - MenA routine support: Central African Republic [French]

Date of Gavi approval:

Proposal for NVS - MenA Campaign support: Central African Republic

Date of Gavi approval:

Proposal for NVS - MenA Campaign support: Central African Republic [French]

Date of Gavi approval:

Proposal for NVS - IPV support: Central African Republic

Date of Gavi approval:

Proposal for NVS - IPV support: Central African Republic [Français]

Date of Gavi approval:

Proposal for NVS - Rota support: Central African Republic

Date of Gavi approval:

Proposal for NVS - Rota support: Central African Republic [Français]

Date of Gavi approval:

Proposal for ISS, NVS - pneumo support: Central African Republic

Date of Gavi approval:

Proposal for NVS - Penta support: Central African Republic

Date of Gavi approval:

Proposal for NVS - Penta support: Central African Republic [Français]

Date of Gavi approval:

Proposal for ISS, NVS - YF, INS support: Central African Republic

Date of Gavi approval:

Proposal for ISS, NVS - YF, INS support: Central African Republic [Français]

Date of Gavi approval:

Comprehensive multi-year plans, Financial sustainability plans, National Immunisation Strategy

The comprehensive multi-year plan (cMYP) is a single plan which consolidates several immunisation activities. It is a key planning and management tool for national immunisation programmes. It addresses global, national, and subnational immunisation objectives and strategies, and evaluates the costs and financing of the programme in line with the WHO-UNICEF Global Immunization Vision and Strategy 2006-2015. Gavi requires countries to submit a cMYP along with the standard proposal form when applying for Gavi support (ISS, INS, and NVS). In 2006, over 50 countries had developed cMYPs using the WHO-UNICEF cMYP guidelines and costing tool.
The cMYP replaces the financial sustainability plan (FSP), used to assess the funding challenges of a country's national immunisation programme within the broader health financing context and to describe the government’s approach to mobilising and effectively using resources to support medium- and long-term immunisation objectives. 

cMYPs Central African Republic 2007-2011

Country co-financing information sheet

The country-specific co-financing sheets provide up-to-date information on countries’ eligibility status, co-financing fulfilment and requirements. They also give a summary of government health expenditure, including immunisation financing.

Specifically, the sheets provide a history of the Gavi-supported vaccines introduced per country, the country’s co-financing payments to date and its co-financing requirements for the current year. In case the country has defaulted on its co-financing requirements, there is an overview of the co-financing arrears of the previous year. Finally, the sheets provide co-financing projections for the next five years based on our latest forecasts.

The information sheets are updated at least twice per year to account for new information on countries’ co-financing fulfilment (in the first quarter) and eligibility status (in the third quarter).

Co-financing information sheet CAR

Co-financing information sheet CAR [Fr]

Decision Letters and Partnerships Agreement

The Decision Letter or Partnership Framework Agreement provides a summary of the details of the new approval or continuation of a Gavi window of support, following the independent review of a new application or annual progress report submitted by a country.

CAR decision letter Measles 2019

Lettre de décision SVN RCA 2015 (3)

Republique Centrafricaine Lettre de decision fievre jaune

Lettre de décision République Centrafricaine Suivi contre la rougeole 2019

Lettre de décision SVN RCA 2015 (2)

Republique Centrafricaine Lettre de decision Men A 2019

Decision Letter MSI - FJ RCA 2018 - French

Lettre de décision SVN RCA 2015

Republique Centrafricaine Lettre de decision pentavalent 2019

Decision Letter Yellow Fever RCA 2018

Lettre de décision SVN RCA 2014(3)

Republique Centrafricaine Lettre de decision pneumo 2019

Lettre de décision RSS RCA 2017

Lettre de décision SVN RCA 2014(2)

Republique Centrafricaine Lettre de decision Polio 2019

Lettre de décision SVN et Matériel RCA 2016

Lettre de décision SVN RCA 2014

Republique Centrafricaine Lettre de decision Securite des injections 2019

Lettre de décision SVN RCA 2016

CAR decision letter Device 2019

Lettre de décision SVN RCA 2016 (2)

Targeted country assistance plans

Targeted country assistance (TCA) are resources provided to in-country partners under Gavi’s partners’ engagement framework (PEF). A country’s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.

Targeted Country Assistance Plan Central African Republic 2021

Targeted Country Assistance Plan Central African Republic 2020

Targeted Country Assistance Plan CAR 2019

Targeted country assistance plan CAR 2018 [French]

Targeted country assistance plan CAR 2017 [French]

Subscribe to our newsletter